deferoxamine mesylate

The medicine is used to remove excess iron or aluminum from the body. It is intended for the treatment of, among others, chronic iron overload (e.g., in individuals requiring frequent blood transfusions, in hemochromatosis or porphyria), the treatment of acute iron poisoning, and the treatment of aluminum overload in patients with renal failure.

Form: powder for preparation of injection solution

ATC: V03AC01

Manufacturer: Novartis Pharma GmbH

The medicine is used to remove excess iron or aluminum from the body. It is intended for the treatment of, among others, chronic iron overload (e.g., in people treated for anemia requiring frequent blood transfusions, in hemochromatosis or porphyria), treatment of acute iron poisoning, and treatment of chronic aluminum overload in patients with end-stage renal failure.

Form: powder for preparation of injection solution

ATC: V03AC01

Manufacturer: Novartis (Hellas) S.A.

The medicine is used to remove excess iron or aluminum from the body. It helps in the treatment of chronic iron overload (e.g., in individuals requiring frequent blood transfusions, in hemochromatosis or porphyria), the treatment of acute iron poisoning, and chronic aluminum overload in patients with renal failure.

Form: powder for preparation of injection solution

ATC: V03AC01

Manufacturer: Novartis Pharma GmbH

The medicine is used to remove excess iron or aluminum from the body. It may be used in chronic iron accumulation (e.g., in individuals requiring frequent blood transfusions, in hemochromatosis or porphyria), in the treatment of acute iron poisoning, and in cases of chronic aluminum accumulation in patients with renal failure.

Form: powder for preparation of injection solution

ATC: V03AC01

Manufacturer: Novartis Europharm Limited